About

David LaVance is the Chairman and CEO of Integrated Environmental Technologies, a public company specializing in providing disinfectants and biocides to industry. He is also the Chairman of the Board of Hologic, Inc., a medical device and diagnostics company headquartered in Boston, and a co-founder of Century Capital Associates LLC. In June 2015, the New York Stock Exchange recognized Mr. LaVance as a finalist at its annual Governance Awards as one of the nation’s best non-executive chairmen for his 15 years of work at Hologic, a $10-billion company. Mr. LaVance specializes in developing life sciences and other emerging technology companies, as well as advising companies about mergers, acquisitions, divestitures and strategic alliances. Mr. LaVance has extensive experience in strategic planning for biotechnology and medical device companies, technology licensing and international distribution. Prior to co-founding Century Capital Associates, Mr. LaVance was a Managing Director of KPMG Health Ventures (1995-1997), a health care consulting group providing M&A, licensing and strategic advisory services. Before joining KPMG Health Ventures, he was a founder of Physicians Data Corporation, a startup health informatics company (1994) and the President of Nuclear Care, Inc., a nuclear imaging clinical services provider (1992–1995). For both companies, he raised venture capital and recruited management. He was the President of Dornier Medical Systems (Japan), Inc., a subsidiary of DaimlerBenz AG, and held a series of operating positions with Dornier in the United States (1987-1992). Dornier was the inventor of and world market leader in lithotripter technologies. Before joining Dornier, Mr. LaVance was Associate Counsel at Healthdyne, Inc. (1985-1986), where he led licensing, OEM and acquisition transaction efforts; and he was engaged in the private practice of law in Atlanta, Georgia (1979-1985). During his career, Mr. LaVance has raised venture capital for several startup businesses and has led the acquisition or sale of numerous medical or high-tech companies. Mr. LaVance holds a B.A., cum laude, from Furman University (1976) and a J.D. from the Washington College of Law of the American University (1979).